Kaye Capital Management’s Amgen AMGN Stock Holding History

Kaye Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$283K	Buy	1,014 +1	+0.1%	+$283	0.11%	38
2025 Q1	$316K	Buy	1,013 +1	+0.1%	+$295	0.13%	38
2024 Q4	$264K	Buy	1,012 +1	+0.1%	+$297	0.12%	36
2024 Q3	$326K	Sell	1,011 -1	-0.1%	-$327	0.13%	33
2024 Q2	$316K	Buy	1,012 +3	+0.3%	+$881	0.13%	32
2024 Q1	$287K	Hold	1,009	–	–	0.13%	33
2023 Q4	$313K	Buy	1,009 +1	+0.1%	+$272	0.14%	30
2023 Q3	$271K	Buy	1,008 +1	+0.1%	+$250	0.12%	31
2023 Q2	$224K	Buy	1,007 +1	+0.1%	+$232	0.11%	30
2023 Q1	$243K	Buy	1,006 +1	+0.1%	+$245	0.12%	31
2022 Q4	$264K	Buy	+1,005	New	+$269K	0.14%	27

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Kaye Capital Management's AMGN Position: Q2 2025 in Review

Kaye Capital Management increased its Amgen (AMGN) stake by 0.1% in Q2 2025, buying an estimated $283 and bringing the position to 1,014 shares worth $283K. The position accounts for 0.11% of the portfolio, ranked #38.

Kaye Capital Management first reported a position in AMGN in Q4 2022 and has held it in 11 quarters since. The position peaked at $326K in Q3 2024. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

Kaye Capital Management held 1,014 shares of Amgen worth $283K as of Q2 2025.
Kaye Capital Management bought 1 Amgen share in Q2 2025, an estimated $283.
Amgen made up 0.11% of Kaye Capital Management's portfolio in Q2 2025, its #38 holding.
Kaye Capital Management first reported a position in Amgen in Q4 2022 and has held it in 11 quarters since.
Kaye Capital Management's Amgen position peaked at $326K in Q3 2024.
2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Kaye Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.